Zinc oxide nanoparticles reduce the chemoresistance of gastric cancer by inhibiting autophagy

BACKGROUND: Gastric cancer (GC) is a common malignancy that results in a high rate of cancer-related mortality. Cisplatin (DDP)-based chemotherapy is the first-line clinical treatment for GC therapy, but chemotherapy resistance remains a severe clinical challenge. Zinc oxide nanoparticle (ZnO-NP) ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, You-Han, Mao, Li-Ping, Cai, Xiao-Juan, Mo, Xiao-Ying, Zhu, Qi-Qi, Yang, Fei-Tong, Wang, Mei-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291011/
https://www.ncbi.nlm.nih.gov/pubmed/34321849
http://dx.doi.org/10.3748/wjg.v27.i25.3851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291011/
https://www.ncbi.nlm.nih.gov/pubmed/34321849
http://dx.doi.org/10.3748/wjg.v27.i25.3851

Ejemplares similares